Molecular Markers: From Diagnosis to Prognosis in 2013
Open Access
- 12 November 2013
- journal article
- Published by Springer Nature in Current Otorhinolaryngology Reports
- Vol. 2 (1) , 35-43
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinomaBMC Cancer, 2012
- An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid CarcinomaPLOS ONE, 2012
- Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate CytologyNew England Journal of Medicine, 2012
- Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysisDiagnostic Pathology, 2012
- Epigenetics Modifications and Therapeutic Prospects in Human Thyroid CancerFrontiers in Endocrinology, 2012
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA SamplesThe Journal of Clinical Endocrinology & Metabolism, 2011
- BRAF in primary and recurrent papillary thyroid cancers: the relationship with 131I and 2-[18F]fluoro-2-deoxy-d-glucose uptake abilityEuropean Journal of Endocrinology, 2010
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid CancerJournal of Clinical Oncology, 2009
- Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma PatientsAnnals of Surgery, 2007
- Preventable reoperations for persistent and recurrent papillary thyroid carcinomaSurgery, 2004